{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:04Z","timestamp":1790985244597,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite their recognized value, the heterogeneous use of PROMs and PREMs prevents standardized data collection across hospitals, limiting their impact on both individual patient care and broader healthcare optimization. This study aims to identify and establish a standardized set of PROMs and PREMs for lung and rectal cancer to support uniform data collection and follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>This multicenter study involved 10 Flemish hospitals focusing on lung and rectal cancer and applied a nine-phase methodology: (1) literature-based identification of PROMs and PREMs, (2) inventory of PROMs and PREMs currently used and proposed by the participating hospitals, (3) systematic assessment of PROM and PREM characteristics, (4) preliminary selection by the research team, (5) a Modified Delphi study with clinical experts, (6) an interview with methodologists, (7) patient focus groups, (8) a consensus meeting with clinical experts, and (9) finalization by the research group. A total of 13 lung cancer experts and 13 rectal cancer experts participated in the modified Delphi study. In addition, interviews were conducted with two methodologists, and five lung cancer patients and five rectal cancer patients, including both current and former patients, took part in the focus groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Consensus-based standardized sets of PROMs for lung and rectal cancer were selected. The final PROM sets consisted of the EQ-5D-5L (generic), EORTC QLQ-C30 and adapted PRO-CTCAE (cancer-specific), EORTC QLQ-LC29 (lung cancer-specific), and the EORTC QLQ-CR29, EORTC QLQ-LMC21 (1 item) and LARS (rectal cancer-specific), and an adapted version of the SF-HLQ for employment-related outcomes in both cancer populations. No PREM met the selection criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Based on a structured multi-phase approach integrating quantitative and qualitative methods with input from both patients and clinical experts, standardized PROM sets were selected for lung and rectal cancer. A specific PREM needs to be developed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-026-01133-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:13:54Z","timestamp":1783484034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selection of patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) for long-term follow up of patients diagnosed with lung or rectal cancer"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2455-395X","authenticated-orcid":false,"given":"Gina","family":"Linmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svin","family":"Deneckere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"van Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"De Gendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Sermeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"14","key":"1133_CR1","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ejca.2011.04.034","volume":"47","author":"LV van de Poll-Franse","year":"2011","unstructured":"van de Poll-Franse LV et al (2011) The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47(14):2188\u20132194","journal-title":"Eur J Cancer"},{"issue":"9","key":"1133_CR2","doi-asserted-by":"publisher","first-page":"100087","DOI":"10.1016\/j.apjon.2022.100087","volume":"9","author":"MI Fitch","year":"2022","unstructured":"Fitch MI (2022) Reducing the global burden of cancer. Asia Pac J Oncol Nurs 9(9):100087","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"3","key":"1133_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"1133_CR4","unstructured":"Available from: https:\/\/kankerregister.org\/nl\/node"},{"key":"1133_CR5","unstructured":"Cancer Fact Sheets (2023) Belgian cancer registry (BCR), 2025"},{"key":"1133_CR6","doi-asserted-by":"crossref","unstructured":"Lachman P, Batalden P, Vanhaecht K (2020) A multidimensional quality model: an opportunity for patients, their kin, healthcare providers and professionals to coproduce health. F1000Res 9:1140","DOI":"10.12688\/f1000research.26368.2"},{"issue":"3","key":"1133_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1377\/hlthaff.27.3.759","volume":"27","author":"DM Berwick","year":"2008","unstructured":"Berwick DM, Nolan TW, Whittington J (2008) The triple aim: care, health, and cost. Health Aff (Millwood) 27(3):759\u2013769","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"1133_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1370\/afm.1713","volume":"12","author":"T Bodenheimer","year":"2014","unstructured":"Bodenheimer T, Sinsky C (2014) From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med 12(6):573\u2013576","journal-title":"Ann Fam Med"},{"issue":"6","key":"1133_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jama.2021.25181","volume":"327","author":"S Nundy","year":"2022","unstructured":"Nundy S, Cooper LA, Mate KS (2022) The Quintuple Aim for Health Care Improvement: A New Imperative to Advance Health Equity. JAMA 327(6):521\u2013522","journal-title":"JAMA"},{"key":"1133_CR10","doi-asserted-by":"crossref","unstructured":"Desomer A, Triemstra VdHK, Paget M, De Boer J, Kohn D, Cleemput L (2018) I. Health Services Research (HSR) Brussel: Belgian Health Care Knowledge Centre (KCE). Het gebruik van pati\u00ebntuitkomsten en -ervaringen (PROMs\/PREMs) voor klinische en beleidsdoeleinden \u2013 Synthese","DOI":"10.57598\/R303AS"},{"issue":"1","key":"1133_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12955-024-02312-4","volume":"22","author":"JM Bonsel","year":"2024","unstructured":"Bonsel JM et al (2024) The use of patient-reported outcome measures to improve patient-related outcomes - a systematic review. Health Qual Life Outcomes 22(1):101","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"1133_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E et al (2017) Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA 318(2):197\u2013198","journal-title":"JAMA"},{"issue":"3","key":"1133_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jama.2018.18085","volume":"321","author":"F Denis","year":"2019","unstructured":"Denis F et al (2019) Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer. JAMA 321(3):306\u2013307","journal-title":"JAMA"},{"key":"1133_CR14","unstructured":"Publishing O (2025) Does healthcare deliver? results from the patient-reported indicator surveys (PaRIS). OECD"},{"issue":"5","key":"1133_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1470-2045(20)30093-0","volume":"21","author":"M Koller","year":"2020","unstructured":"Koller M et al (2020) Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol 21(5):723\u2013732","journal-title":"Lancet Oncol"},{"issue":"6","key":"1133_CR16","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00520-021-06029-8","volume":"29","author":"A Coolbrandt","year":"2021","unstructured":"Coolbrandt A et al (2021) Real-time symptom management in the context of a remote symptom-monitoring system: prospective process evaluation and cross-sectional survey to explore clinical relevance. Support Care Cancer 29(6):3401\u20133408","journal-title":"Support Care Cancer"},{"issue":"2","key":"1133_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/0269216313491619","volume":"28","author":"B Antunes","year":"2014","unstructured":"Antunes B et al (2014) Implementing patient-reported outcome measures in palliative care clinical practice: a systematic review of facilitators and barriers. Palliat Med 28(2):158\u2013175","journal-title":"Palliat Med"},{"issue":"11","key":"1133_CR18","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s11136-020-02564-9","volume":"30","author":"AM Stover","year":"2021","unstructured":"Stover AM et al (2021) Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings. Qual Life Res 30(11):3015\u20133033","journal-title":"Qual Life Res"},{"key":"1133_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41687-018-0072-3","volume":"2","author":"A Foster","year":"2018","unstructured":"Foster A et al (2018) The facilitators and barriers to implementing patient reported outcome measures in organisations delivering health related services: a systematic review of reviews. J Patient Rep Outcomes 2:46","journal-title":"J Patient Rep Outcomes"},{"key":"1133_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.lungcan.2021.10.010","volume":"162","author":"I Demedts","year":"2021","unstructured":"Demedts I et al (2021) Clinical implementation of value based healthcare: Impact on outcomes for lung cancer patients. Lung Cancer 162:90\u201395","journal-title":"Lung Cancer"},{"issue":"6","key":"1133_CR21","first-page":"e13653","volume":"31","author":"S Misplon","year":"2022","unstructured":"Misplon S et al (2022) Evaluation of the implementation of Value-Based Healthcare with a weekly digital follow-up of lung cancer patients in clinical practice. Eur J Cancer Care (Engl) 31(6):e13653","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1133_CR22","unstructured":"Corporation R. Available from: https:\/\/www.rand.org\/topics\/delphi-method.html"},{"issue":"8","key":"1133_CR23","doi-asserted-by":"publisher","first-page":"e2424793","DOI":"10.1001\/jamanetworkopen.2024.24793","volume":"7","author":"AK Balitsky","year":"2024","unstructured":"Balitsky AK et al (2024) Patient-Reported Outcome Measures in Cancer Care: An Updated Systematic Review and Meta-Analysis. JAMA Netw Open 7(8):e2424793","journal-title":"JAMA Netw Open"},{"key":"1133_CR24","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.jcpo.2025.100618","volume":"45","author":"CL Moss","year":"2025","unstructured":"Moss CL et al (2025) Implementing patient reported outcomes in cancer care: Lessons and strategies from a large UK Cancer Centre. J Cancer Policy 45:100618","journal-title":"J Cancer Policy"},{"key":"1133_CR25","doi-asserted-by":"crossref","unstructured":"Akkad N, Flowers CR (2025) Patient-reported outcome measures (PROMS) in Lymphoma. Curr Oncol 32(5)","DOI":"10.3390\/curroncol32050265"},{"issue":"8","key":"1133_CR26","doi-asserted-by":"publisher","first-page":"e2424748","DOI":"10.1001\/jamanetworkopen.2024.24748","volume":"7","author":"MJ Hassett","year":"2024","unstructured":"Hassett MJ, Cronin C (2024) Patient-Reported Outcome Measures Help Patients With Cancer. JAMA Netw Open 7(8):e2424748","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-026-01133-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01133-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01133-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:03:49Z","timestamp":1790982229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41687-026-01133-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1186\/s41687-026-01133-x","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was granted by the Ethics Committee of UZ Leuven on March 17, 2023 (S67403). The study was conducted in accordance with the Declaration of Helsinki. Funding for the PROOF project was provided by Kom op tegen Kanker.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"179"}}